Humana Reports Second Quarter 2020 Financial Results; Continues Proactive Relief Efforts Amid Pandemic
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Humana (HUM) PT Raised to $425 at Cantor Fitzgerald
August 5, 2020 1:06 PM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Humana (NYSE: HUM) to $425.00 (from $410.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our OW rating on HUM and increase our price target to $425 from $410. On Wed., August 5, Humana reported better-than-expected... More
Humana (HUM) Tops Q2 EPS by $2.29, Offers FY Guidance
August 5, 2020 6:32 AM EDTHumana (NYSE: HUM) reported Q2 EPS of $12.56, $2.29 better than the analyst estimate of $10.27. Revenue for the quarter came in at $19.08 billion versus the consensus estimate of $18.63 billion.
GUIDANCE:
Humana sees FY2020 EPS of $18.25-$18.75, versus the consensus of $18.72.
Humana is revising its GAAP EPS guidance range for the year ending December 31, 2020 (FY 2020) to $17.36 to $17.86... More